Explore all subjects

The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

GLG News by Generic Pharmaceuticals Regulation Experts: Healthcare Consultants

David Zimmerman, PharmD, President/Owner
Doctors of Pharmacy, Inc.
Analysis of: Cialis Is Cleared for Daily Use (online.wsj.com)
    Physicians have been prescribing lower dose Cialis...off label... for a long time. The FDA finally agreed and approved it.
Analysis of: GlaxoSmithKline receives FDA 'complete response' letter for cervical cancer vaccine (www.pipelinereview.com)
GlaxoSmithKline has gained a complete response letter from the U.S. Food and Drug Administration related to its application for the cervical cancer vaccine, CERVARIX®. This likely means approval is 2-4 weeks away, but it could also mean months to years.
Analysis of: Lu AA21004 for the treatment of mood and anxiety disorders enters into clinical phase III (www.pipelinereview.com)
The study population is acceptably large, not based in Denmark – which is good there are not enough people there – so the study is worldwide and more representative of the Market this drug will reach. Payments to Lundbeck from Takeda are fair and agreeable. The clinical results for Phase II necessitate...
Analysis of: New Phase 3 Data Showed PRISTIQ Significantly Reduced Symptoms of Major Depressive Disorder Versus Placebo (www.pipelinereview.com)
PRISTIQ can be expected to take massive market share from other Major Depressive Disorder (MDD) products. While Wyeth has lost little of its multi billion dollar market share when it collaborated with TEVA to market the IR and ER forms -- one can expect PRISTIQ to flatten the market out and control...
Analysis of: Dow Chemical to cut 1,000 jobs (www.processingmagazine.com)
Loss of 1000 jobs in North America, Asia and Latin America and Southern America, USA. Expectations of $180 Million Dollar Savings.
Analysis of: Forest Laboratories and Lundbeck announces positive results of Lexapro(R) phase III study in adolescents with major depression (www.pipelinereview.com)
study population size no evaluation for suicide and suicidal feelings
Analysis of: Study Shows Weight-Loss Drug Rimonabant is Associated with Severe Adverse Psychiatric Events (pharmalive.com)
Rimonabant was studied for approval to exclude individuals with psychiatric disorders. Now, it is found that there is a link associated with rimonabant and severe psychiatric disorders to include increase risk of suicide.
Analysis of: GPC Biotech Announces Corporate Restructuring (www.pipelinereview.com)
GPC Biotech AG (Frankfurt Stock Exchange: GPC; TecDAX index; NASDAQ: GPCB) has sent a signal to the community.  It needs 2 years cash on hand and much less of its already small workforce.  This could imply the executives are preparing cushions for themselves when the firm folds. ...
Analysis of: Topps Meat files for bankruptcy after huge beef recall (www.processingmagazine.com)
E. Coli is a hazard to humans and can cause illness and death.  Once processing equipment is contaminated proper cleaning of the equipment can be hard.
Analysis of: Merck to pay $4.85 billion Vioxx settlement (www.processingmagazine.com)
Pharmaceutical lawsuits in the United States are costly.  In other places in the world and pharmaceutical lawsuit nearly a unicorn. There are three main players in these actions: The injured, the cause of injury, and the lawyers.

Previous Page : 1 2 3 4 5 6 7 8 9 10 11 12 13 Next31 to 40 of 179

Analytics


Generated at 2009-01-07T13:00:17.563